about
Intravenous immunoglobulin for Guillain-Barré syndromeThe Production Processes and Biological Effects of Intravenous ImmunoglobulinRapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodiesUse of intravenous immunoglobulin in pediatric practiceRole of cytokines and Toll-like receptors in the immunopathogenesis of Guillain-Barré syndromeTherapeutic plasma exchange in neurology: 2012.Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europeIntravenous immunoglobulin as clinical immune-modulating therapy.Peripheral nervous system manifestations of infectious diseasesIntravenous immunoglobulin vs plasma exchange in treatment of mechanically ventilated adults with Guillain-Barré syndrome.Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia.Traditional Chinese medicine Yisui Tongjing relieved neural severity in experimental autoimmune neuritis rat model.Immunotherapy in Peripheral NeuropathiesGuillain-Barre syndrome as a paraneoplastic manifestation of disseminated squamous cell carcinomaRegulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy.Occurrence of hemolytic anemia in patients with GBS treated with high-dose IVIg.Immunomodulation by IVIg and the Role of Fc-Gamma Receptors: Classic Mechanisms of Action after all?Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.Efficacy of Polyvalent Human Immunoglobulins in an Animal Model of Neuromyelitis Optica Evoked by Intrathecal Anti-Aquaporin 4 Antibodies.Extrahepatic manifestations of acute hepatitis B virus infection.The devil is in the detail: Acute Guillain-Barré syndrome camouflaged as neurosarcoidosis in a critically ill patient admitted to an Intensive Care Unit.Intravenous immunoglobulin for treatment of neuromuscular disease.
P2860
Q24193522-BAE63703-62E4-414A-B09E-A4265CB59A8EQ26752540-16067398-BA68-49D1-8E12-25954FC34035Q26864907-21237E03-AB98-4AC0-9061-2BCB9BF24988Q27011481-C7F5C2D4-3771-4D03-8403-85B61A50FF62Q27027324-1515F290-C174-4358-9915-51A7126DC9BBQ30415046-B54BE72A-50DF-42E4-953E-DF1262DB6D8EQ33419638-78D81F19-4BED-4EDF-8FC1-DD798E9B3946Q33420267-83B34A49-EBCD-4F9C-BF8C-DB6A1DF3EC7DQ34418510-A8D283B2-C90D-4ADC-B0A7-624DEA79A858Q34431762-A8BBD019-E723-46C0-9258-E20D852B0B7CQ34844126-E6A1AD93-256E-4E6C-9BA6-9E0FEDC26400Q36161072-5E3D55C2-DC67-4D8B-B4C7-D310CC0EA696Q36484418-D088539E-F621-4B31-98F2-98E27D5B398EQ36894028-A4F70ACC-3676-4A4A-873F-6DC8E455469EQ37713650-D1C96ADE-A646-401A-A39C-96DB501B0FC8Q38292793-B57A0C45-BE37-44AD-949E-46812C440430Q38344833-6F1DCC06-1383-4DEA-8D99-B27C6D70B73BQ39009373-51566680-BCC8-4D5D-83D2-EE8730803BE1Q39444161-CA6605C4-23B5-4F77-A60D-F7EF74AFC1A3Q42102531-D0267FB2-CE61-434F-84EA-020155B1A1E0Q42724209-1FD8F067-B1EC-4FF3-AC34-909D4B6426C6Q50133537-A804EC32-E549-4C9E-8A8C-BA523DACEB45
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Intravenous immunoglobulin for Guillain-Barré syndrome
@ast
Intravenous immunoglobulin for Guillain-Barré syndrome
@en
Intravenous immunoglobulin for Guillain-Barré syndrome
@en-gb
Intravenous immunoglobulin for Guillain-Barré syndrome
@nl
type
label
Intravenous immunoglobulin for Guillain-Barré syndrome
@ast
Intravenous immunoglobulin for Guillain-Barré syndrome
@en
Intravenous immunoglobulin for Guillain-Barré syndrome
@en-gb
Intravenous immunoglobulin for Guillain-Barré syndrome
@nl
prefLabel
Intravenous immunoglobulin for Guillain-Barré syndrome
@ast
Intravenous immunoglobulin for Guillain-Barré syndrome
@en
Intravenous immunoglobulin for Guillain-Barré syndrome
@en-gb
Intravenous immunoglobulin for Guillain-Barré syndrome
@nl
P2860
P3181
P1476
Intravenous immunoglobulin for Guillain-Barré syndrome
@en
P2093
Anthony V Swan
Richard AC Hughes
P2860
P3181
P356
10.1002/14651858.CD002063.PUB5
P577
2012-07-11T00:00:00Z